STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) Free cash flow margin
STERIS plc's free cash flow margin over the twelve months to 30 June 2026 was 15.5%, down 1.1 percentage points from fiscal 2026 (16.6%). Over the past ten years it has ranged from 5.77% (fiscal 2016) to 16.6% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −7.24% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | 16.6% | 2.14 |
| FY2025 | 14.4% | 2.35 |
| FY2024 | 12.1% | 3.04 |
| FY2023 | 9.03% | (0.42) |
| FY2022 | 9.45% | (5.06) |
| FY2021 | 14.5% | 1.97 |
| FY2020 | 12.5% | (0.23) |
| FY2019 | 12.8% | 1.54 |
| FY2018 | 11.2% | 1.43 |
| FY2017 | 9.80% | 4.03 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DXCM DexCom, Inc. compare | 28.3% |
| GMED Globus Medical, Inc. compare | 24.0% |
| STE STERIS plc | 15.5% |
| PEN Penumbra, Inc. compare | 14.4% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 13.6% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 12.2% |
| PHG Koninklijke Philips N.V. compare | 8.99% |
| GEHC GE HealthCare Technologies Inc. compare | 7.42% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −7.24% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement